NCT06473168View on ClinicalTrials.gov

Mobility Assessment in Multi-morbidity

Not yet recruitingOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
ArthritisAsthmaAtrial FibrillationBronchiectasisCancerChronic Kidney DiseasesChronic Obstructive Pulmonary DiseaseCoronary Heart DiseaseAnxietyDepressionDiabetes MellitusHeart FailureHypertensionOsteoporosisParkinson DiseasePeripheral Vascular DiseaseStrokeTransient Ischemic Attack
All Listed Sponsors
collaborator

Newcastle University

OTHER

lead

Northumbria University

OTHER

NCT06473168 - Mobility Assessment in Multi-morbidity | Biotech Hunter | Biotech Hunter